Trade NAUT anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Nautilus Biotechnology, Inc. (NAUT) is trading at US$0.88, down 2.78% today as of Aug 28, 12:35 EDT. The company has a market capitalisation of US$121.47M. Over the past 52 weeks, NAUT has traded between US$0.62 and US$4.31. On Syfe you can trade NAUT with $0 commission and add it to your watchlist.
| Previous close | US$0.90 |
|---|---|
| Market cap | US$121.47M |
| 52-week range | US$0.62 – US$4.31 |
| Volume | 522.51K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Nautilus Biotechnology, Inc.
Nautilus Biotechnology, Inc. is a development stage life sciences company, which creates platform technology for quantifying and unlocking the complexity of the proteome. Its products include Proteome Analysis System, Reagent Kits, and Software and Analysis. The company was founded by Sujal M. Patel and Parag Mallick in 2016 and is headquartered in Seattle, WA.
Year: 2021
Nautilus Biotechnology, Inc. (NAUT) stock is trading at US$0.88, -2.78% from the previous close of US$0.90.
The market cap for Nautilus Biotechnology, Inc. (NAUT) stock is approximately US$121.47M.
The 52-week high for Nautilus Biotechnology, Inc. (NAUT) stock is US$4.31.
The 52-week low for Nautilus Biotechnology, Inc. (NAUT) stock is US$0.62.
Nautilus Biotechnology, Inc. (NAUT) does not currently pay a dividend.
Stay on top of NAUT
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
